1-8 of 8
Kristina Kleboth
Close
Sort by
Journal Articles

Survival Improvement of Patients with Chronic Lymphocytic Leukemia (CLL) in Routine Care 1995 - 2017

Rudolf Weide, Prof., Stefan Feiten, Geothy Chakupurakal, MBBS, MRCPath, PhD, Vera Friesenhahn, Kristina Kleboth, Hubert Köppler, Prof., Julia Lutschkin, Jörg Thomalla, MD, Christoph van Roye, MD, Jochen Heymanns, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4823.
https://doi.org/10.1182/blood-2018-99-109862
Published: 2018
Journal Articles

Reality of Care for Patients with Multiple Myeloma 1995-2016. New Drugs in Routine Care Lead to Improved Survival

Rudolf Weide, Prof., Stefan Feiten, Geothy Chakupurakal, MBBS, MRCPath, PhD, Vera Friesenhahn, Kristina Kleboth, Julia Lutschkin, Jörg Thomalla, MD, Christoph van Roye, MD, Jochen Heymanns, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5628.
https://doi.org/10.1182/blood.V130.Suppl_1.5628.5628
Published: 2017
Journal Articles

Survival Improvement of Patients with Chronic Lymphocytic Leukemia (CLL) in Routine Care. a Retrospective Analysis of All Patients with CLL Who Were Treated in an Oncology Group Practice in Germany Between 1995-2015

Rudolf Weide, Prof., Stefan Feiten, Geothy Chakupurakal, MBBS, MRCPath, PhD, Vera Friesenhahn, Kristina Kleboth, Julia Lutschkin, Jörg Thomalla, MD, Christoph van Roye, MD, Jochen Heymanns, MD, Hubert Köppler, Prof.
Journal: Blood
Blood (2016) 128 (22): 5961.
https://doi.org/10.1182/blood.V128.22.5961.5961
Published: 2016
Journal Articles

Treatment Reality of Patients with Immune Thrombocytopenia (ITP) in Routine Care

Rudolf Weide, MD, Stefan Feiten, Vera Friesenhahn, Jochen Heymanns, MD, Kristina Kleboth, Jörg Thomalla, MD, Christoph van Roye, MD, Hubert Köppler, Prof. Dr.
Journal: Blood
Blood (2014) 124 (21): 5009.
https://doi.org/10.1182/blood.V124.21.5009.5009
Published: 2014
Journal Articles

Bendamustine + Rituximab-Combinations and R-CHOP Achieve a Major Survival Improvement Of Patients With Follicular Lymphoma In Routine Care

Rudolf Weide, Prof. Dr., Stefan Feiten, Vera Friesenhahn, Jochen Heymanns, MD, Kristina Kleboth, Jörg Thomalla, MD, Christoph van Roye, MD, Hubert Köppler, Prof. Dr.
Journal: Blood
Blood (2013) 122 (21): 5584.
https://doi.org/10.1182/blood.V122.21.5584.5584
Published: 2013
Journal Articles

Bendamustine and Rituximab Achieve a Major Survival Improvement Of Patients With Morbus Waldenström In Routine Care

Rudolf Weide, Stefan Feiten, Vera Friesenhahn, Jochen Heymanns, MD, Kristina Kleboth, Jörg Thomalla, MD, Christoph van Roye, MD, Hubert Köppler
Journal: Blood
Blood (2013) 122 (21): 5611.
https://doi.org/10.1182/blood.V122.21.5611.5611
Published: 2013
Journal Articles

Sequential Treatment With Bendamustine, Rituximab, Chlorambucil and Fludarabine Leads To a Major Survival Improvement Of Patients With Chronic Lymphocytic Leukemia (CLL) In Routine Care

Rudolf Weide, Stefan Feiten, Vera Friesenhahn, Jochen Heymanns, MD, Kristina Kleboth, Jörg Thomalla, MD, Christoph van Roye, MD, Hubert Köppler
Journal: Blood
Blood (2013) 122 (21): 5613.
https://doi.org/10.1182/blood.V122.21.5613.5613
Published: 2013
Journal Articles

Retherapy with Bendamustine-Containing Regimens in Patients with Relapsed/Refractory CLL and Indolent Lymphomas Achieves High Response Rates

Rudolf Weide, Dr., Stefan Feiten, Vera Friesenhahn, Jochen Heymanns, MD, Kristina Kleboth, Jörg Thomalla, MD, Christoph van Roye, MD, Hubert Köppler, Dr.
Journal: Blood
Blood (2011) 118 (21): 1615.
https://doi.org/10.1182/blood.V118.21.1615.1615
Published: 2011